News | News By Subject | News by Disease News By Date | Search News

HIV/AIDS News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
The Drugmaker That Could Knock Gilead (GILD) Off Its HIV Throne     9/20/2016
GlaxoSmithKline (GSK) Execs Set High Hopes for Game-Changing HIV Research Strategy     8/29/2016
Gilead (GILD)'s Odefsey Successful in Two Phase IIIb Studies     7/22/2016
Theratechnologies (TH.TO) Says 82.5% of Patients Achieved Primary Endpoint in Phase III Ibalizumab Trial     5/24/2016
FDA Approves Gilead (GILD)'s Next-Generation HIV Drug Descovy     4/5/2016
FDA Green Lights Gilead (GILD)’s Odefsey to Treat HIV-1 Infection in Certain Patients     3/2/2016
GlaxoSmithKline (GSK) Does Late Holiday Shopping, Buys Two HIV Asset Programs from Bristol-Myers Squibb (BMY) For Up to $2 Billion     12/18/2015
ViiV Healthcare Hitting Hard But Gilead (GILD) Management is Well-Prepared     11/4/2015
Imprimis (immy) Offers $1 Alternative to Turing Pharma's $750 AIDS Drug     10/23/2015
Gilead (GILD)'s New HIV Drug Genvoya Shows Lower Side-Effects Over Longer Term in Two Late-Stage Studies     10/22/2015
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
GlaxoSmithKline (GSK)'s ViiV Healthcare Successful But Heat From Gilead (GILD) May Be Its Downfall     7/9/2015
Johnson & Johnson (JNJ) HIV Vaccine Blocks Virus in 50% of Monkeys, Soon to Start Human Trial in 400     7/9/2015

News from Around the Web
HIV Vaccine A Step Closer, The Scripps Research Institute Study     9/13/2016
Is There Anyone The Drug Industry Hates More Than This AIDS Activist?     9/6/2016
First Next-Generation Sequencing Test For HIV Drug Resistance Could Help Combat AIDS Worldwide, Vela Diagnostics Reveals     8/4/2016
A Different Way To Test For HIV Or Allergens, University of Florida Study     7/26/2016
Vaginal Ring May Cut HIV Infection Risk If Used Consistently, NIAID Study     7/19/2016
Drugs That Saved HIV Patients Now Threaten Them In Old Age     7/6/2016
Startup Targets HIV Drug Resistance In Developing Countries, Aldatu Biosciences Reveals     6/16/2016
In Pursuit Of An HIV Vaccine And The AIDS-Free Generation     5/17/2016
First Liver Transplant Between HIV-Positive Donor And Recipient Marks Milestone For HIV Patients, Johns Hopkins University Reveals     3/31/2016
Scientists Eliminate HIV-1 From DNA Of Human T-Cells, Temple University Reveals     3/24/2016
Stanford University Chemists Develop An Ultra-Sensitive Test For Cancers, HIV     3/21/2016
Ultra-Sensitive Test Developed For Cancers, HIV, Stanford University Chemists Reveal     3/11/2016
Hospital Warns 213 Patients May Have Been Exposed To Hepatitis, HIV Due To Tampering of Drugs By Ex-Employee     2/26/2016
Investors Aren't Impressed as Charlie Sheen Reveals He Wants in on Tiny CytoDyn (CYDY)'s HIV Drug Trial     2/12/2016
Nixing Latex: Building The Perfect Condom With Hydrogel, Plant-Based Antioxidants, Texas A&M University Study     12/1/2015

Press Releases
University Of Natural Resources And Life Sciences Release: Hidden HIV Revealed: New Insights Into Latent HIV Infections     9/26/2016
Selexis SA And IAVI Expand Collaboration To Advance Multiple HIV Vaccine Candidates Toward Clinical Testing     9/22/2016
Selexis SA And International AIDS Vaccine Initiative Expand Collaboration to Advance Multiple HIV Vaccine Candidates Toward Clinical Testing     9/22/2016
Mymetics And Texas Biomedical Research Institute Continue Collaboration On HIV Vaccine Development     9/19/2016
Aphios To Develop HIV/AIDS Cure Using Combination Drugs In Targeted ‘Nanosomes’ Nanoparticles     9/13/2016
Janssen-Cilag AG Submits Marketing Authorisation Application For Darunavir-Based Single Tablet Regimen For Treatment Of HIV-1 To EMA     9/12/2016
Kymouse, Kymab's Human Antibody Discovery Platform, Successfully Demonstrates Steps To Developing HIV Vaccine     9/9/2016
Cepheid (CPHD) Targets Development Of A Point Of Care HIV Viral Load Test From A Few Drops Of Blood     9/9/2016
Sedia Biosciences Awarded Additional $1.8 Million NIH Grant For Novel Rapid HIV Test For Recent Infections     8/30/2016
CytoDyn (CYDY) Release: Patients Approach Two Years Of Complete HIV Viral Load Suppression In Phase IIb PRO 140 Monotherapy Extension Study     8/23/2016
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Once-Daily Truvada® For Reducing The Risk Of Sexually Acquired HIV-1     8/22/2016
ViiV Healthcare Launches Phase III Programme Evaluating A Two-Drug Regimen Combining Dolutegravir And Lamivudine For HIV-1 Treatment     8/16/2016
The Division Of AIDS Awards ABL A Seven-Year Contract To Provide HIV Microbicide Research And Product Development Support     7/26/2016
CytoDyn (CYDY) Submits Orphan Drug Application To FDA For Pretreatment With PRO 140 Of Treatment-Naïve HIV Patients     7/21/2016
GlaxoSmithKline (GSK)'s Cervarix Is First HPV Vaccine Approved For China Use     7/20/2016